The clinical efficacy of AG NPP709 (Synatura(®)) in patients with chronic bronchitis type stable chronic obstructive pulmonary disease

BACKGROUND: AG NPP709 (Synatura(®)) has been demonstrated to be efficacious in decreasing cough and sputum in patients with acute upper respiratory infection and chronic inflammatory bronchitis. The aim of this study was to evaluate the efficacy of AG NPP709 in patients with chronic bronchitis type...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Eung Gu, Rhee, Chin Kook
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7330415/
https://www.ncbi.nlm.nih.gov/pubmed/32642149
http://dx.doi.org/10.21037/jtd.2020.03.61

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7330415/
https://www.ncbi.nlm.nih.gov/pubmed/32642149
http://dx.doi.org/10.21037/jtd.2020.03.61

Ejemplares similares